Soreno: Siobhan McCrudden, a Psoriasis
oderate-to-severe psoriasis patients fare better using Raptiva over placebo treatments, according to results from Serono's 24-week clinical study CLEAR (Clinical Experience Acquired with Raptiva). Serono officials say the study confirms the effectiveness and safety with continued use of Raptiva compared to placebo in patients who either continued after an initial 12-week therapy to receive treatment up to 24 weeks, or who received re-treatment for an additional 12 weeks following a treatment-free observation period.
Embed code for Blogs
Simply copy and paste the following HTML code below into your blog, website, or MySpace profile.
Copy to Clipboard
Share this video:
Simply click the button below and select your social bookmarking site.
Tag Cloud
Category: Health & Care
oderate-to-severe psoriasis patients fare better using Raptiva over placebo treatments, according to results from Serono's 24-week clinical study CLEAR (Clinical Experience Acquired with Raptiva). Serono officials say the study...
Views: 8808















The relationship of Ethanol production to the price of food
American Lung Association: Asthma PSA
American Lung Association: Freedom from Smoking 2
World Food Program: Sean Connery
Stop Alcohol Abuse: David
Beijing Olympics One-Year-to-Go celebrations
George Clooney: Reporting from Darfur Part 2
American Lung Association 100th anniversary
Verizon: Hope Line PSA
Blood Donation - Gold Reserve
UNICEF Zimbabwe mobilizes nation for week-long immunization and health drive
UNICEF: Gender Equality - Coco's Story
UNICEF: Supplies distributed in the wake of conflict in Goma, DR Congo
Hepatitis C PSA with actor Christopher Kennedy Lawford
UNICEF - Niger child trafficking
Hybridfest - The largest hybrid car show
American Lung Association: Nobody Likes to Kiss an Ashtray
Intel International Science and Engineering Fair
UNICEF: Gambia Health Clinic